<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39457150</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9067</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>28</Day></PubDate></JournalIssue><Title>Children (Basel, Switzerland)</Title><ISOAbbreviation>Children (Basel)</ISOAbbreviation></Journal><ArticleTitle>A Comparison of Kawasaki Disease during the SARS-CoV-2 Pandemic with Multisystem Inflammatory Syndrome in Children.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1185</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/children11101185</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The purpose of this study was to compare and contrast Kawasaki disease (KD) with multisystem inflammatory syndrome in children (MIS-C) during the SARS-CoV-2 pandemic.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective analysis of the medical records of patients diagnosed with KD and MIS-C at a single institution from July 2020 to November 2021 was performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The study included 39 MIS-C patients (84.6% male) with a median age of 138 months and 17 KD patients (58.8% male) with a median age of 36 months. The MIS-C patients were older (<i>p</i> &lt; 0.001) and had prolonged hospitalizations (<i>p</i> = 0.023), elevated neutrophil counts (<i>p</i> &lt; 0.001), C-reactive protein (<i>p</i> &lt; 0.001), procalcitonin (<i>p</i> &lt; 0.001), interleukin-6 (<i>p</i> &lt; 0.014), ferritin (<i>p</i> &lt; 0.001), fibrinogen (<i>p</i> &lt; 0.001), troponin I (<i>p</i> = 0.001), NT-proBNP (<i>p</i> &lt; 0.001), and D-dimer levels (<i>p</i> &lt; 0.001). There were more cases of hypotension (<i>p</i> = 0.024), decreased left ventricular function (<i>p</i> = 0.023), and a greater need for corticosteroids (<i>p</i> &lt; 0.001), enoxaparin (<i>p</i> = 0.045), and therapeutic plasma exchange (<i>p</i> &lt; 0.001). Kawasaki disease patients had a greater incidence of rash (<i>p</i> &lt; 0.001), changes in oral mucosa (<i>p</i> &lt; 0.001), conjunctival injection (<i>p</i> &lt; 0.001), extremity changes (<i>p</i> &lt; 0.001), and cervical lymphadenopathy (<i>p</i> &lt; 0.001). They had a longer duration of fever (<i>p</i> &lt; 0.001), elevated white blood cell count (<i>p</i> &lt; 0.001), platelet count (<i>p</i> &lt; 0.001), and alanine aminotransferase level (<i>p</i> &lt; 0.001). The two groups were similar regarding the hemoglobin levels, erythrocyte sedimentation rates, albumin levels, and the frequency of coronary aneurysm, myocarditis, pericarditis, invasive mechanical ventilatory support, and intravenous immunoglobulin treatment.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Advanced patient age, a greater presence of gastrointestinal and cardiac findings associated with hypotension, increased NT-proBNP levels, decreased left ventricular function, the use of various treatment modalities, and longer hospital stays suggest MIS-C, whereas prolonged fever and classical clinical features of KD favor KD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tunçer</LastName><ForeName>Tunç</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Pediatric Cardiology, School of Medicine, Bulent Ecevit University, 67000 Zonguldak, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varol</LastName><ForeName>Fatih</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Pediatric Intensive Care Unit, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Saglik Bilimleri University, 34785 Istanbul, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Children (Basel)</MedlineTA><NlmUniqueID>101648936</NlmUniqueID><ISSNLinking>2227-9067</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Kawasaki disease</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">multisystem inflammatory syndrome in children</Keyword></KeywordList><CoiStatement>The authors certify that there are no conflicts of interest with any financial organization regarding the material discussed in the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39457150</ArticleId><ArticleId IdType="pmc">PMC11505943</ArticleId><ArticleId IdType="doi">10.3390/children11101185</ArticleId><ArticleId IdType="pii">children11101185</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Whittaker E., Bamford A., Kenny J., Kaforou M., Jones C.E., Shah P., Ramnarayan P., Fraisse A., Miller O., Davies P., et al. Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2. JAMA. 2020;324:259–269. doi: 10.1001/jama.2020.10369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.10369</ArticleId><ArticleId IdType="pmc">PMC7281356</ArticleId><ArticleId IdType="pubmed">32511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdoni L., Mazza A., Gervasoni A., Martelli L., Ruggeri M., Ciuffreda M., Bonanomi E., D’Antiga L. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: An observational cohort study. Lancet. 2020;395:1771–1778. doi: 10.1016/S0140-6736(20)31103-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31103-X</ArticleId><ArticleId IdType="pmc">PMC7220177</ArticleId><ArticleId IdType="pubmed">32410760</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung E.W., Zachariah P., Gorelik M., Boneparth A., Kernie S.G., Orange J.S., Milner J.D. Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City. JAMA. 2020;324:294–296. doi: 10.1001/jama.2020.10374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.10374</ArticleId><ArticleId IdType="pmc">PMC7281352</ArticleId><ArticleId IdType="pubmed">32511676</ArticleId></ArticleIdList></Reference><Reference><Citation>Toubiana J., Poirault C., Corsia A., Bajolle F., Fourgeaud J., Angoulvant F., Debray A., Basmaci R., Salvador E., Biscardi S., et al. Kawasaki-like multisystem inflammatory syndrome in children during the COVID-19 pandemic in Paris, France: Prospective observational study. BMJ. 2020;369:m2094. doi: 10.1136/bmj.m2094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2094</ArticleId><ArticleId IdType="pmc">PMC7500538</ArticleId><ArticleId IdType="pubmed">32493739</ArticleId></ArticleIdList></Reference><Reference><Citation>Riphagen S., Gomez X., Gonzalez-Martinez C., Wilkinson N., Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607–1608. doi: 10.1016/S0140-6736(20)31094-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31094-1</ArticleId><ArticleId IdType="pmc">PMC7204765</ArticleId><ArticleId IdType="pubmed">32386565</ArticleId></ArticleIdList></Reference><Reference><Citation>Belhadjer Z., Méot M., Bajolle F., Khraiche D., Legendre A., Abakka S., Auriau J., Grimaud M., Oualha M., Beghetti M., et al. Acute heart failure in multisystem inflammatory syndrome in children in the context to global SARS-CoV-2 pandemic. Circulation. 2020;142:429–436. doi: 10.1161/CIRCULATIONAHA.120.048360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.048360</ArticleId><ArticleId IdType="pubmed">32418446</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein L.R., Rose E.B., Horwitz S.M., Collins J.P., Newhams M.M., Son M.B.F., Newburger J.W., Kleinman L.C., Heidemann S.M., Martin A.A., et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N. Engl. J. Med. 2020;383:334–346. doi: 10.1056/NEJMoa2021680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021680</ArticleId><ArticleId IdType="pmc">PMC7346765</ArticleId><ArticleId IdType="pubmed">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Multisystem Inflammatory Syndrome in Children and Adolescents with COVID-19: Scientific Brief 2020.  [(accessed on 17 August 2024)].  Available online:  https://www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention Health Alert Network (HAN)  Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19)  [(accessed on 17 August 2024)]; Available online:  https://archive.cdc.gov/#/details?url=https://emergency.cdc.gov/han/2020/han00432.asp.</Citation></Reference><Reference><Citation>McCrindle B.W., Rowley A.H., Newburger J.W., Burns J.C., Bolger A.F., Gewitz M., Baker A.L., Jackson M.A., Takahashi M., Shah P.B., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American Heart Association. Circulation. 2017;135:927–999. doi: 10.1161/CIR.0000000000000484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000484</ArticleId><ArticleId IdType="pubmed">28356445</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivas M.N., Arditi M. Kawasaki Disease and Multisystem Inflammatory Syndrome in Children Common Inflammatory Pathways of Two Distinct Diseases. Rheum. Dis. Clin. N. Am. 2023;49:647–659. doi: 10.1016/j.rdc.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rdc.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10020039</ArticleId><ArticleId IdType="pubmed">37331738</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabeerdoss J., Pilania R.K., Karkhele R., Kumar T.S., Danda D., Singh S. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: Immunological mechanisms, clinical manifestations and management. Rheumatol. Int. 2021;41:19–32. doi: 10.1007/s00296-020-04749-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-020-04749-4</ArticleId><ArticleId IdType="pmc">PMC7680080</ArticleId><ArticleId IdType="pubmed">33219837</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafferty M.S., Burrows H., Joseph J.P., Leveille J., Nihtianova S., Amirian E.S. Amirian ES. Multisystem inflammatory syndrome in children (MIS-C) and the coronavirus pandemic: Current knowledge and implications for public health. J. Infect. Public Health. 2021;4:484–494. doi: 10.1016/j.jiph.2021.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2021.01.008</ArticleId><ArticleId IdType="pmc">PMC7813487</ArticleId><ArticleId IdType="pubmed">33743370</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurup S., Burgess R., Tine F., Chahroudi A., Lee D.L. SARS-CoV-2 Infection and Racial Disparities in Children: Protective Mechanisms and Severe Complications Related to MIS-C. J. Racial Ethn. Health Disparities. 2022;9:1536–1542. doi: 10.1007/s40615-021-01092-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40615-021-01092-7</ArticleId><ArticleId IdType="pmc">PMC8276539</ArticleId><ArticleId IdType="pubmed">34255304</ArticleId></ArticleIdList></Reference><Reference><Citation>Javalkar K., Robson V.K., Gaffney L., Bohling A.M., Arya P., Servattalab S., Roberts J.E., Campbell J.I., Sekhavat S., Newburger J.W., et al. Socioeconomic and Racial and/or Ethnic Disparities in Multisystem Inflammatory Syndrome. Pediatrics. 2021;147:5. doi: 10.1542/peds.2020-039933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-039933</ArticleId><ArticleId IdType="pmc">PMC8086000</ArticleId><ArticleId IdType="pubmed">33602802</ArticleId></ArticleIdList></Reference><Reference><Citation>Godfred-Cato S.D., Abrams J.Y., Balachandran N.M., Jaggi P., Jones K.M., Rostad C.A., Lu A.T.B., Fan L.B., Jabbar A., Anderson E.J., et al. Distinguishing multisystem inflammatory syndrome in children from COVID-19, Kawasaki Disease and toxic shock syndrome. Pediatr. Infect. Dis. J. 2022;41:315–323. doi: 10.1097/INF.0000000000003449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003449</ArticleId><ArticleId IdType="pmc">PMC8919949</ArticleId><ArticleId IdType="pubmed">35093995</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma C., Ganigara M., Galeotti C., Burns J., Berganza F.M., Hayes D.A., Singh-Grewal D., Bharath S., Sajjan S., Bayry J. Multisystem inflammatory syndrome in children and Kawasaki disease: A critical comparison. Nat. Rev. Rheumatol. 2021;17:731–748. doi: 10.1038/s41584-021-00709-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00709-9</ArticleId><ArticleId IdType="pmc">PMC8554518</ArticleId><ArticleId IdType="pubmed">34716418</ArticleId></ArticleIdList></Reference><Reference><Citation>Haslak F., Gunalp A., Kasapcopur O. A cursed goodbye kiss from severe acute respiratory syndrome-coronavirus-2 to its pediatric hosts: Multisystem inflammatory syndrome in children. Curr. Opin. Rheumatol. 2023;35:6–16. doi: 10.1097/BOR.0000000000000910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000910</ArticleId><ArticleId IdType="pubmed">36094472</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashir A., Bhat A.A., Jan M., Wani K.A. Kawasaki like illness in COVID versus Kawasaki disease in pre-COVID era. Int. J. Contemp. Pediatr. 2023;10:484–487.</Citation></Reference><Reference><Citation>Phi D.L., Dao T.L., To M.M., Nguyen T.B., Nguyen D.C., Gautret P., Hoang V.T. Clinical and Laboratory Characteristics of Kawasaki Disease and COVID-19-Related Multisystem Inflammatory Syndrome in Children. J. Korean Med. Sci. 2023;38:e410. doi: 10.3346/jkms.2023.38.e410.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2023.38.e410</ArticleId><ArticleId IdType="pmc">PMC10727921</ArticleId><ArticleId IdType="pubmed">38111281</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattalini M., Della Paolera S., Zunica F., Bracaglia C., Giangreco M., Verdoni L., Meini A., Sottile R., Caorsi R., Zuccotti G., et al. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: Results from a national, multicenter survey. Pediatr. Rheumatol. Online J. 2021;19:29. doi: 10.1186/s12969-021-00511-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-021-00511-7</ArticleId><ArticleId IdType="pmc">PMC7962084</ArticleId><ArticleId IdType="pubmed">33726806</ArticleId></ArticleIdList></Reference><Reference><Citation>Bar-Meir M., Guri A., Godfrey M.E., Shack A.R., Hashkes P.J., Goldzweig O., Megged O. Characterizing the differences between multisystem inflammatory syndrome in children and Kawasaki disease. Sci. Rep. 2021;11:13840. doi: 10.1038/s41598-021-93389-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93389-0</ArticleId><ArticleId IdType="pmc">PMC8257717</ArticleId><ArticleId IdType="pubmed">34226639</ArticleId></ArticleIdList></Reference><Reference><Citation>Yavuz L., AlHamdani S., Alasrawi S., Wafadari D., Al-Fraihat A., Bebars M.A., Nath J., Arango D., Pallavidino M., Jain R., et al. Kawasaki disease (KD) and multisystem inflammatory syndrome in children (MIS-C) in a Middle Eastern patient cohort. Pediatr. Rheumatol. Online J. 2023;21:64. doi: 10.1186/s12969-023-00834-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-023-00834-7</ArticleId><ArticleId IdType="pmc">PMC10308603</ArticleId><ArticleId IdType="pubmed">37386568</ArticleId></ArticleIdList></Reference><Reference><Citation>Cem E., Böncüoğlu E., Kıymet E., Şahinkaya Ş., Çelebi M.Y., Gülderen M., Kaçar P., Kara A.A., Aydın A., Murat M., et al. Which Findings Make multisystem Inflammatory Syndrome in Children Different from the Pre-Pandemic Kawasaki Disease? Pediatr. Cardiol. 2023;44:424–432. doi: 10.1007/s00246-022-02961-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-022-02961-6</ArticleId><ArticleId IdType="pmc">PMC9282145</ArticleId><ArticleId IdType="pubmed">35804239</ArticleId></ArticleIdList></Reference><Reference><Citation>Ünlü A.M., Holm M., Hafstrøm T.K., Glerup M., Bjerre J., Herlin T. Changes in Kawasaki disease incidence and phenotype during the COVID-19 pandemic. Dan Med. J. 2023;70:A10220600.</Citation><ArticleIdList><ArticleId IdType="pubmed">37341355</ArticleId></ArticleIdList></Reference><Reference><Citation>Iio K., Matsubara K., Miyakoshi C., Ota K., Yamaoka R., Eguchi J., Matsumura O., Okutani T., Ueda I., Nishiyama M. Incidence of Kawasaki disease before and during the COVID-19 pandemic: A retrospective cohort study in Japan. BMJ Paediatr. Open. 2021;5:e001034. doi: 10.1136/bmjpo-2021-001034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjpo-2021-001034</ArticleId><ArticleId IdType="pmc">PMC8023747</ArticleId><ArticleId IdType="pubmed">33884312</ArticleId></ArticleIdList></Reference><Reference><Citation>Şener S., Batu E.D., Akca Ü.K., Atalay E., Cüceoğlu M.K., Balık Z., Başaran Ö., Karagöz T., Özsürekçi Y., Bilginer Y., et al. Differentiating Multisystem Inflammatory Syndrome in Children from Kawasaki Disease During the Pandemic. Turk. Arch. Pediatr. 2024;59:150–156. doi: 10.5152/TurkArchPediatr.2024.23192.</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/TurkArchPediatr.2024.23192</ArticleId><ArticleId IdType="pmc">PMC11059258</ArticleId><ArticleId IdType="pubmed">38454223</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarı E., Erdede Ö. Comparison of Eosinophil Counts in Inflammatory Conditions: Multisystem Inflammatory Syndrome in Children, Kawasaki Disease, and Infectious Mononucleosis. Children. 2024;11:204. doi: 10.3390/children11020204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children11020204</ArticleId><ArticleId IdType="pmc">PMC10887273</ArticleId><ArticleId IdType="pubmed">38397316</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciftdogan D.Y., Keles Y.E., Cetin B.S., Karabulut N.D., Emiroglu M., Bagci Z., Buyukcam A., Erdeniz E.H., Arga G., Yesil E., et al. COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group. Eur. J. Pediatr. 2022;181:2031–2043. doi: 10.1007/s00431-022-04390-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04390-2</ArticleId><ArticleId IdType="pmc">PMC8819197</ArticleId><ArticleId IdType="pubmed">35129668</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrban S., Tahghighi F., Moghadam E.A., Ziaee V. Multisystem inflammatory syndrome in children and Kawasaki disease; comparison of their clinical findings and one-year follow-up—A cross-sectional study. Ital. J. Pediatr. 2023;49:90. doi: 10.1186/s13052-023-01489-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-023-01489-6</ArticleId><ArticleId IdType="pmc">PMC10360261</ArticleId><ArticleId IdType="pubmed">37475054</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkan F., Bircan O., Bal A., Bayturan S., Zengin N., Coskun S. Comparison of early characteristics of multisystemic inflammatory syndrome and Kawasaki disease in children and the course of Kawasaki disease in the pandemic. BMC Pediatr. 2024;24:485. doi: 10.1186/s12887-024-04966-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-024-04966-x</ArticleId><ArticleId IdType="pmc">PMC11290103</ArticleId><ArticleId IdType="pubmed">39080588</ArticleId></ArticleIdList></Reference><Reference><Citation>Consiglio C.R., Cotugno N., Sardh F., Pou C., Amodio D., Rodriguez L., Tan Z., Zicari S., Ruggiero A., Pascucci G.R., et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell. 2020;183:968–981. doi: 10.1016/j.cell.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7474869</ArticleId><ArticleId IdType="pubmed">32966765</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsubara D., Kauffman H.L., Wang Y., Calderon-Anyosa R., Nadaraj S., Elias M.D., White T.J., Torowicz D.L., Yubbu P., Giglia T.M., et al. Echocardiographic Findings in Pediatric Multisystem Inflammatory Syndrome Associated with COVID-19 in the United States. J. Am. Coll. Cardiol. 2020;76:1947–1961. doi: 10.1016/j.jacc.2020.08.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.08.056</ArticleId><ArticleId IdType="pmc">PMC7467656</ArticleId><ArticleId IdType="pubmed">32890666</ArticleId></ArticleIdList></Reference><Reference><Citation>Belay E.D., Abrams J., Oster M.E., Giovanni J., Pierce T., Meng L., Prezzato E., Balachandran N., Openshaw J.J., Rosen H.E., et al. Trends in geographic and temporal distribution of US children with multisystem inflammatory syndrome during the COVID-19 pandemic. JAMA Pediatr. 2021;175:837–845. doi: 10.1001/jamapediatrics.2021.0630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.0630</ArticleId><ArticleId IdType="pmc">PMC8025123</ArticleId><ArticleId IdType="pubmed">33821923</ArticleId></ArticleIdList></Reference><Reference><Citation>Fridman D.M., Tsoukas P., Jeewa A., Yeung R.S.M., Gamulka B.D., McCrindle B.W. Differentiation of COVID-19 Associated Multisystem Inflammatory Syndrome From Kawasaki Disease with the Use of Cardiac Biomarkers. Can. J. Cardiol. 2023;39:815–823. doi: 10.1016/j.cjca.2022.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2022.11.012</ArticleId><ArticleId IdType="pmc">PMC9711900</ArticleId><ArticleId IdType="pubmed">36462758</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchesi A., de Jacobis I.T., Rigante D., Rimini A., Malorni W., Corsello G., Bossi G., Buonuomo S., Cardinale F., Cortis E., et al. Kawasaki disease: Guidelines of Italian Society of Pediatrics, part II—Treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks. Ital. J. Pediatr. 2018;44:103. doi: 10.1186/s13052-018-0529-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-018-0529-2</ArticleId><ArticleId IdType="pmc">PMC6116479</ArticleId><ArticleId IdType="pubmed">30157893</ArticleId></ArticleIdList></Reference><Reference><Citation>Pouletty M., Borocco C., Ouldali N., Caseris M., Basmaci R., Lachaume N., Bensaid P., Pichard S., Kouider H., Morelle G., et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): A multicentre cohort. Ann. Rheum. Dis. 2020;79:999–1006. doi: 10.1136/annrheumdis-2020-217960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217960</ArticleId><ArticleId IdType="pmc">PMC7299653</ArticleId><ArticleId IdType="pubmed">32527868</ArticleId></ArticleIdList></Reference><Reference><Citation>Akca U.K., Atalay E., Cuceoglu M.K., Balik Z., Sener S., Ozsurekci Y., Basaran O., Batu E.D., Bilginer Y., Ozen S. Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases. Rheumatol. Int. 2022;42:51–57. doi: 10.1007/s00296-021-05027-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-05027-7</ArticleId><ArticleId IdType="pmc">PMC8561687</ArticleId><ArticleId IdType="pubmed">34727197</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>